What was a major outcome of the FDA Modernization Act of 1997?

The FDA Modernization Act of 1997 aimed to streamline the drug approval process, which included measures to increase the speed at which new drugs could be brought to market. It introduced provisions like allowing the use of fast-track processes for drugs intended to treat serious or life-threatening conditions. By facilitating a more efficient approval process, the Act significantly reduced the time and barriers for pharmaceutical companies to gain access to the market, ultimately enhancing patient access to new medications. This modernization reflects a balance between ensuring safety and efficacy while also meeting public health needs more promptly.

The focus of the Act was not on prohibiting drug advertising, mandating ingredient disclosure, or specifically regulating dietary supplements; rather, it emphasized improving the FDA's ability to oversee the introduction of new therapies in a more timely manner.